BPAP是常规CPAP治疗失败的肥胖OSA患者的有效二线疗法:一项前瞻性观察性队列研究
该前瞻性观察性队列研究纳入2014至2017年间因CPAP依从性差(使用<4小时/天)而转诊至三级睡眠中心的52例OSA患者,评估BPAP的疗效。结果显示BPAP所需的呼气正压更低,患者对BPAP的依从性更好(7.0 vs 2.5小时/晚,P=0.028),症状控制也更佳(ESS:4.0 vs 10.0分,P=0.039)。结论认为,对于因低依从性导致CPAP治疗失败的中重度OSA患者,BPAP耐受良好并能充分控制睡眠呼吸障碍及其症状。
要点
- BPAP所需呼气正压低于CPAP(10 vs 16.8 cm H2O,P=0.001)。
- BPAP依从性优于CPAP(7.0 vs 2.5小时/晚,P=0.028)。
- BPAP症状控制优于CPAP(ESS:4.0 vs 10.0分,P=0.039)。
核心结论
- 对于因低依从性导致CPAP治疗失败的中重度OSA患者,BPAP耐受良好并能充分控制睡眠呼吸障碍及其症状。
研究设计与样本
- 前瞻性观察性队列研究,纳入2014至2017年间因CPAP治疗失败(使用<4小时/天)而转诊至三级睡眠中心接受BPAP的52例OSA患者。
主要发现
- BPAP所需呼气正压低于CPAP(10(8-12)vs 16.8(15.7-19.2)cm H2O,P=0.001)。
- BPAP依从性优于CPAP(7.0(4.0-8.5)vs 2.5(1.6-6.7)小时/晚,P=0.028)。
- BPAP症状控制优于CPAP(ESS:4.0(1.0-7.0)vs 10.0(6.0-17.0)分,P=0.039)。
临床怎么用
- 对于CPAP治疗失败(依从性低)的中重度OSA患者,可考虑换用BPAP作为二线治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Continuous positive airway pressure (CPAP) is the most common treatment for obstructive sleep apnoea (OSA), but many patients fail long-term therapy. Bilevel positive airway pressure (BPAP) is a potential alternative. We hypothesized that BPAP could improve treatment adherence and outcomes in patients who cannot tolerate CPAP. METHODS: Patients with OSA who failed CPAP (usage < 4 h/day) and were referred to a tertiary sleep centre between 2014 and 2017 for BPAP were included. Age, gender, body mass index (BMI), co-morbidities, CPAP use and reasons for failure, Epworth Sleepiness Scale (ESS), sleep study data, spirometry data and average maximum nightly compliance were recorded. RESULTS: A total of 52 patients with OSA requiring CPAP > 15 cm H2 O (71% male, age: 58 (15) years, BMI: 42.6 (10.1) kg/m2 , apnoea-hypopnoea index (AHI): 51.1 (30.4)/h) were studied; 62% had respiratory co-morbidities affecting nocturnal breathing including obesity hypoventilation syndrome and COPD; 25% had neuromuscular conditions; and 17% had cardiovascular disease. CPAP was used for 199 (106-477) days prior to referral for BPAP. Reasons for CPAP failure were intolerant pressures (23%), uncontrolled symptoms (23%), mask problems (21%), adverse effects (13%), claustrophobia (8%), co-morbidities (8%) and other issues (4%). Lower expiratory positive airway pressures were needed with BPAP compared to CPAP (10 (8-12) vs 16.8 (15.7-19.2) cm H2 O, P = 0.001); patients achieved better adherence to BPAP (7.0 (4.0-8.5) vs 2.5 (1.6-6.7) h/night, P = 0.028) and better symptom control (ESS: 4.0 (1.0-7.0) vs 10.0 (6.0-17.0) points, P = 0.039). CONCLUSION: In patients with moderate-severe OSA who fail CPAP therapy due to low adherence, BPAP is well tolerated and achieves sufficient control of sleep-disordered breathing and its symptoms.
引用
- Ishak A, Ramsay M, Hart N, et al. BPAP is an effective second-line therapy for obese patients with OSA failing regular CPAP: A prospective observational cohort study. Respirology. 2019. PMID: 31407464. doi:10.1111/resp.13674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。